Manufacturer of Aten 25 mg
Aten 25 mg tablet is manufactured by Zydus Cadila Healthcare Ltd.
Content of Aten 25 mg tablet
Aten tablet contains Atenolol .It is a selective beta 1 receptor antagonist and belonging to the class of beta blockers.Beta blockers are primarily used for the treatment of cardiovascular diseases.
Indications of Aten 25 mg
- Angina
- Myocardial infarction
- Arrhythmias
- Hypertension
- Migraine prophylaxis
Contraindications of Aten 25 mg
- Asthma
- Uncontrolled heart failure
- Prinzmetal's angina or Variant angina
- Marked bradycardia
- Hypotension
- Sick sinus syndrome
- Second and third degree atrioventricular block
- Cardiogenic shock
- Metabolic acidosis
- Severe peripheral arterial disease
Precautions of Aten 25 mg
- Avoid abrupt withdrawal especially in angina;it may worsen heart failure
- Acute myocardial infraction
- Thyrotoxicosis
- Renel diseases
- Diabetes mellitus
- History of hypersensitivity reactions
- Pregnancy
- Lactation
Adverse effects of Aten 25 mg
- Anorexia
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
- Bronchospasam
- Bradycardia
- Head ache
- Fatigue
- Drowsiness
- Confusion
- Delirium
- Hallucinations
- Depression
- Sleep disturbances
- Hypotension
- Skin rashes
- Hypoglycemia or hyperglycemia
- Exacerbation of psoriasis
- Dry eyes
If any of the event occurred please contact your concerned doctor .
Pregnancy category –D
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
0 comments:
Post a Comment